Evogene (EVGN) — Strategic Asset Allocation Index
Evogene (EVGN) has a Strategic Asset Allocation Index of 0.0% as of September 2025. Strategic assets (PP&E of ILA- plus long-term investments of ILA0.00) total ILA0.00, measured against net assets of ILA17.25 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check EVGN asset resilience ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Evogene Strategic Asset Allocation Index (2006–2024)
This chart shows how Evogene's Strategic Asset Allocation Index has evolved across 19 annual periods from 2006 to 2024. As of September 2025, the index stands at 0.0%, representing strategic assets of ILA0.00 against net assets of ILA17.25 Million ILA. See EVGN FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Evogene (2006–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Evogene from 2006 to 2024, covering 19 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market cap of Evogene.
| Year | SAAI | Strategic Assets (ILA) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 0.6% | ILA82.00K | ILA- | ILA82.00K | ILA14.84 Million | ▲ +0.6 pp |
| 2023 | 0.0% | ILA0.00 | ILA- | ILA0.00 | ILA28.68 Million | ▼ -11.7 pp |
| 2022 | 11.7% | ILA4.07 Million | ILA4.07 Million | ILA- | ILA34.79 Million | ▲ +5.1 pp |
| 2021 | 6.6% | ILA4.18 Million | ILA4.18 Million | ILA- | ILA63.42 Million | ▼ -0.3 pp |
| 2020 | 6.9% | ILA3.94 Million | ILA3.94 Million | ILA- | ILA56.88 Million | ▼ -1.8 pp |
| 2019 | 8.7% | ILA5.25 Million | ILA5.25 Million | ILA- | ILA60.22 Million | ▲ +2.4 pp |
| 2018 | 6.3% | ILA3.19 Million | ILA3.19 Million | ILA- | ILA50.31 Million | ▼ -0.6 pp |
| 2017 | 6.9% | ILA4.79 Million | ILA4.79 Million | ILA- | ILA69.38 Million | ▼ -0.5 pp |
| 2016 | 7.4% | ILA6.48 Million | ILA6.48 Million | ILA- | ILA87.29 Million | ▼ -0.5 pp |
| 2015 | 7.9% | ILA8.20 Million | ILA8.20 Million | ILA- | ILA103.75 Million | ▼ 0.0 pp |
| 2014 | 7.9% | ILA9.19 Million | ILA8.81 Million | ILA382.00K | ILA116.08 Million | ▲ +1.8 pp |
| 2013 | 6.2% | ILA7.69 Million | ILA7.21 Million | ILA471.00K | ILA124.75 Million | ▼ -9.2 pp |
| 2012 | 15.3% | ILA7.40 Million | ILA7.40 Million | ILA- | ILA48.26 Million | ▲ +0.5 pp |
| 2011 | 14.8% | ILA7.14 Million | ILA7.14 Million | ILA- | ILA48.09 Million | ▼ -9.8 pp |
| 2010 | 24.6% | ILA4.12 Million | ILA4.12 Million | ILA- | ILA16.73 Million | ▲ +6.8 pp |
| 2009 | 17.8% | ILA3.44 Million | ILA3.44 Million | ILA- | ILA19.34 Million | ▲ +3.6 pp |
| 2008 | 14.1% | ILA1.36 Million | ILA1.36 Million | ILA- | ILA9.61 Million | ▲ +1.1 pp |
| 2007 | 13.0% | ILA742.00K | ILA742.00K | ILA- | ILA5.71 Million | ▲ +2.7 pp |
| 2006 | 10.3% | ILA1.69 Million | ILA1.69 Million | ILA- | ILA16.36 Million | — |